Blueprint Medicines Corp (BPMC)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Aug 13, 16:00
Blueprint Medicines Price : 129.46 for Aug. 13, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Aug 12, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Aug 11, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Aug 08, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Aug 07, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Aug 06, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Aug 05, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Aug 04, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Aug 01, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 31, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 30, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 29, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 28, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 25, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 24, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 23, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 22, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 21, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 18, 2025 | 129.46 | 129.46 | 129.46 | 129.46 | 0.000 |
| Jul 17, 2025 | 129.35 | 129.55 | 129.30 | 129.46 | 2.981M |
| Jul 16, 2025 | 129.34 | 129.65 | 129.20 | 129.28 | 25.68M |
| Jul 15, 2025 | 129.33 | 129.40 | 129.31 | 129.35 | 5.221M |
| Jul 14, 2025 | 129.30 | 129.47 | 129.25 | 129.36 | 6.669M |
| Jul 11, 2025 | 129.32 | 129.35 | 129.00 | 129.30 | 3.570M |
| Jul 10, 2025 | 129.49 | 129.49 | 129.23 | 129.33 | 5.984M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.16 |
| Amgen, Inc. | 391.91 |
| Altimmune, Inc. | 3.315 |
| Amarantus Bioscience Holdings, Inc. | 0.0000 |
| Aligos Therapeutics, Inc. | 5.73 |